Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Deferred Taxes: 2016-2025

Historic Deferred Taxes for Mimedx Group (MDXG) over the last 5 years, with Sep 2025 value amounting to -$5.8 million.

  • Mimedx Group's Deferred Taxes fell 105.03% to -$5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.0 million, marking a year-over-year decrease of 132.50%. This contributed to the annual value of -$12.5 million for FY2024, which is 132.99% down from last year.
  • Latest data reveals that Mimedx Group reported Deferred Taxes of -$5.8 million as of Q3 2025, which was down 1,903.83% from -$287,000 recorded in Q2 2025.
  • Mimedx Group's 5-year Deferred Taxes high stood at $37.8 million for Q4 2023, and its period low was -$5.8 million during Q3 2025.
  • Over the past 3 years, Mimedx Group's median Deferred Taxes value was -$2.2 million (recorded in 2024), while the average stood at $2.3 million.
  • Its Deferred Taxes has fluctuated over the past 5 years, first plummeted by 106.16% in 2024, then skyrocketed by 94.59% in 2025.
  • Mimedx Group's Deferred Taxes (Quarterly) stood at $37.8 million in 2023, then plummeted by 106.16% to -$2.3 million in 2024, then crashed by 105.03% to -$5.8 million in 2025.
  • Its Deferred Taxes stands at -$5.8 million for Q3 2025, versus -$287,000 for Q2 2025 and -$621,000 for Q1 2025.